Data presented at the 2021 World Conference on Lung Cancer painted a bleak picture regarding mesothelioma and COVID-19 infection.
The Vall d’Hebron University Hospital in Barcelona, Spain, reported a nearly 20% infection rate among pleural mesothelioma patients. More alarming was that more than half of the patients with COVID-19 died from the virus.
According to presenters at the conference, seven people with malignant pleural mesothelioma contracted COVID-19 during the first year of the pandemic. This was out of 38 total patients at the hospital.
They were diagnosed with a reverse transcription polymerase chain reaction test. The median survival following mesothelioma diagnosis was roughly 17 months.
The mortality and hospitalization rates are quite alarming. Of the seven COVID-19 cases:
- Five died, a mortality rate of 71%
- Four of the deaths were attributed to COVID, meaning more than half the patients who contracted COVID passed away from the virus
- Six (85%) of the seven patients were hospitalized
One death was attributed to progressive cancer disease. The average time to death was two weeks following COVID diagnosis.
The relationship between COVID-19 and mesothelioma is well-reported. Mesothelioma Guide published multiple articles in 2020 detailing why mesothelioma patients should be extra cautious about COVID infection.
COVID-19, a deadly airborne virus, has affected the world population for nearly two years. The United States is experiencing another surge despite the availability of vaccines. News outlets report worrisome breakthrough cases due to waning vaccine effectiveness. There’s a push for booster shots to strengthen the immunity of people vaccinated from the spring.
COVID-19 has a stronger health impact on people with cancer, particularly malignancies of or around the lungs. Pleural mesothelioma forms near the lungs, specifically in the thin lining between the lungs and chest wall. It often spreads to the lungs and requires lung resection surgery.
COVID is a respiratory illness. It attacks the lungs and causes trouble breathing. The combination of COVID and pleural mesothelioma tumors significantly weakens the lungs.
Sources & Author
- COVID-19 Leads to High Hospitalization and Mortality in Malignant Pleural Mesothelioma. OncLive. Retrieved from: https://www.onclive.com/view/covid-19-leads-to-high-hospitalization-and-mortality-in-malignant-pleural-mesothelioma. Accessed: 09/09/2021.
Sources & Author